发明名称 QUINOXALINEDIONE NMDA RECEPTOR ANTAGONISTS.
摘要 <p>Compounds of formula (I) wherein R1 and R2 are each independently F, Cl, Br, CH3, CH2CH3 or CF3; R3 is H, CH3 or CH2CH3; and X is a 5-membered heterocyclic group containing up to four nitrogen atoms, attached via a nitrogen atom, the said group being optionally benzofused and/or substituted by C1-C6 alkyl or (CH2)nNR4R5, wherein n is an integer from 1 to 5 and R4 and R5 are each independently H, C1-C6 alkyl, C3-C6 cycloalkyl or C1-C4 alkyl substituted by phenyl or pyridyl, or R4 and R5 are linked to form, together with the nitrogen atom to which they are attached, a pyrrolidine, piperidine, piperazine, N-(C1-C4 alkyl) piperazine, morpholine or azepine group; and their pharmaceutically acceptable salts, are NMDA antagonists of utility in the treatment of acute neurodegenerative disorders, e.g. arising from stroke or traumatic head injury and in chronic neurological disorders, e.g. senile dementia and Alzheimer's disease.</p>
申请公布号 MX9701894(A) 申请公布日期 1997.06.28
申请号 MX19970001894 申请日期 1995.09.01
申请人 PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V.;/S.A. 发明人 CHARLES ERIC MOWBRAY;ALAN STOBIE;DAVID JOHN BULL
分类号 C07D401/14;A61K31/495;A61K31/535;A61P25/08;A61P25/20;A61P25/28;A61P43/00;C07D403/06;(IPC1-7):C07D403/06 主分类号 C07D401/14
代理机构 代理人
主权项
地址